These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33561443)

  • 21. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
    Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
    J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crk1/2 and CrkL play critical roles in maintaining podocyte morphology and function.
    Du J; Meng L; Pang L; Jin B; Duan N; Huang C; Huang H; Li H
    Exp Cell Res; 2020 Sep; 394(1):112135. PubMed ID: 32535035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses.
    Hrincius ER; Wixler V; Wolff T; Wagner R; Ludwig S; Ehrhardt C
    Cell Microbiol; 2010 Jun; 12(6):831-43. PubMed ID: 20088952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CrkI and p130(Cas) complex regulates the migration and invasion of prostate cancer cells.
    Dai Y; Qi L; Zhang X; Li Y; Chen M; Zu X
    Cell Biochem Funct; 2011 Dec; 29(8):625-9. PubMed ID: 22144090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
    Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
    Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophilins control T lymphocyte adhesion and migration by regulating CrkII binding to C3G.
    Nath PR; Dong G; Braiman A; Isakov N
    J Immunol; 2014 Oct; 193(8):3966-77. PubMed ID: 25225668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell shape-based chemical screening reveals an epigenetic network mediated by focal adhesions.
    Kanazawa T; Michida H; Uchino Y; Ishihara A; Zhang S; Tabata S; Suzuki Y; Imamoto A; Okada M
    FEBS J; 2021 Oct; 288(19):5613-5628. PubMed ID: 33768715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CrkII transgene induces atypical mammary gland development and tumorigenesis.
    Fathers KE; Rodrigues S; Zuo D; Murthy IV; Hallett M; Cardiff R; Park M
    Am J Pathol; 2010 Jan; 176(1):446-60. PubMed ID: 20008144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells.
    Rodrigues SP; Fathers KE; Chan G; Zuo D; Halwani F; Meterissian S; Park M
    Mol Cancer Res; 2005 Apr; 3(4):183-94. PubMed ID: 15831672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.
    Heikkinen LS; Kazlauskas A; Melén K; Wagner R; Ziegler T; Julkunen I; Saksela K
    J Biol Chem; 2008 Feb; 283(9):5719-27. PubMed ID: 18165234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
    Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
    Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRKL overexpression suppresses in vitro proliferation, invasion and migration of murine hepatocarcinoma Hca-P cells.
    Lin Q; Sun MZ; Guo C; Shi J; Chen X; Liu S
    Biomed Pharmacother; 2015 Feb; 69():11-7. PubMed ID: 25661331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRKL knockdown promotes in vitro proliferation, migration and invasion, in vivo tumor malignancy and lymph node metastasis of murine hepatocarcinoma Hca-P cells.
    Shi J; Meng L; Sun MZ; Guo C; Sun X; Lin Q; Liu S
    Biomed Pharmacother; 2015 Apr; 71():84-90. PubMed ID: 25960220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRKL plays a pivotal role in tumorigenesis of head and neck squamous cell carcinoma through the regulation of cell adhesion.
    Yanagi H; Wang L; Nishihara H; Kimura T; Tanino M; Yanagi T; Fukuda S; Tanaka S
    Biochem Biophys Res Commun; 2012 Feb; 418(1):104-9. PubMed ID: 22244889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.
    Jankowski W; Saleh T; Pai MT; Sriram G; Birge RB; Kalodimos CG
    Nat Chem Biol; 2012 May; 8(6):590-6. PubMed ID: 22581121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation.
    Shi CS; Tuscano J; Kehrl JH
    Blood; 2000 Feb; 95(3):776-82. PubMed ID: 10648385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
    Guo C; Zhao D; Zhang Q; Liu S; Sun MZ
    Sci Rep; 2018 Feb; 8(1):2375. PubMed ID: 29403024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of Crk adaptor proteins to host cell and bacteria interactions.
    Martinez-Quiles N; Feuerbacher LA; Benito-León M; Hardwidge PR
    Biomed Res Int; 2014; 2014():372901. PubMed ID: 25506591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.
    Miller CT; Chen G; Gharib TG; Wang H; Thomas DG; Misek DE; Giordano TJ; Yee J; Orringer MB; Hanash SM; Beer DG
    Oncogene; 2003 Sep; 22(39):7950-7. PubMed ID: 12970743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
    Shi X; Xiao X; Yuan N; Zhang S; Yuan F; Wang X
    Oncol Res; 2018 Aug; 26(7):987-996. PubMed ID: 29295725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.